Related Experiment Video
Updated: Jun 17, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
What to do if standard therapy for hepatitis C fails
1Address: Department of Hepatology, Imperial College, St Mary's Campus, South Wharf Road, London W2 1NY, UK.
Abstract:
The standard of care for treatment of individuals chronically infected with hepatitis C virus is pegylated interferon in combination with ribavirin. Efficacy is closely related to viral genotype. This review outlines potential therapeutic strategies for treatment failures and discusses some of the newer agents currently in development.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Retrovirus Life Cycles
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Viral Hepatitis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
